BVT Knock-Out PGR/ DE000VD0XS89 /
23/05/2024 17:03:29 | Chg.+0.090 | Bid17:44:06 | Ask17:44:06 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.280EUR | +4.11% | 2.300 Bid Size: 16,000 |
2.320 Ask Size: 16,000 |
Progressive Corporat... | 229.50 - | 31/12/2078 | Put |
GlobeNewswire
14:15
Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treat...
GlobeNewswire
14:00
Pinellas REALTOR Organization/Central Pasco REALTOR Organization and Greater Tampa REALTORS Approve ...
GlobeNewswire
22/05
89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Asso...
GlobeNewswire
22/05
Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
GlobeNewswire
21/05
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire
20/05
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
20/05
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire
20/05
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire
20/05
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
16/05
BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire
15/05
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
GlobeNewswire
14/05
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire
13/05
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
13/05
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
13/05
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
09/05
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
09/05
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
08/05
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
07/05
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...